C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2004
12/23/2004	WO2003097805A3 Delivery of nucleic acid-like compounds
12/23/2004	WO2003089898A3 Determining biochemical markers of progression and therapy monitoring and specification, therapeutic lead molecules, and target biochemical systems applied to stroke
12/23/2004	WO2003083436A3 Fibrinogen binding moieties
12/23/2004	WO2003077852A8 CARTILAGE REGENERATION USING CHONDROCYTE AND TGF-β
12/23/2004	WO2003076569A3 Novel polypeptides having sequence similarity to gdnfr and nucleic acids encoding the same
12/23/2004	WO2003063679A8 Hepatitis e virus clones and methods of their use
12/23/2004	WO2003052075A3 Enzymes
12/23/2004	WO2003050236A3 Human genes and gene expression products isolated from human prostate
12/23/2004	WO2003035910A9 Transfection kinetics and structural promoters
12/23/2004	US20040261149 Short interference RNA (siRNA); resistant to geminivirus; transgenic tobacco plants
12/23/2004	US20040261148 Monoclonal antibodies with effector function; signal sequences
12/23/2004	US20040261147 High level production of arbutin in green plants and microbes
12/23/2004	US20040261146 Genes coding for flavone synthases
12/23/2004	US20040261145 Crossbreeding, transferring donor DNA cassettes to acceptor plant (of differing species) for site-directed mutagenesis, providing recombinase, recovering transgenic haploid cell, then generating transgenic plant
12/23/2004	US20040261143 Targeted and regional cellular ablation in zebrafish
12/23/2004	US20040261141 Animal model for therapy of diseases of the eye
12/23/2004	US20040261140 For analyzing inflammatory response associated with cystic fibrosis; screening compounds which inhibit or prevent the recruitment of neutrophils
12/23/2004	US20040261139 Androgen receptor knock-out transgenic animals
12/23/2004	US20040261137 In which genome encodes human glycogen synthase kinase-3 polypeptide via regulatory sequences; for screening potential agents for the treatment of diabetes and obesity; kits
12/23/2004	US20040260079 Cardiac-cell specific enhancer elements and uses thereof
12/23/2004	US20040260078 Novel polynucleotides and polypeptides in pathogenic mycobacteria and their use as diagnostics, vaccines and targets for chemotherapy
12/23/2004	US20040260069 Modified anti-tnf aplha antibody
12/23/2004	US20040260065 Interleukins; immunoglobulins; for stimulating proliferation and/or development of hematopoietic cells in vitro and in vivo
12/23/2004	US20040260062 Stress-responsive activator of p300 (strap) protein
12/23/2004	US20040260060 Under control of tryptophan operon in prokaryotic host cell; gene overexpression due to point mutations, site-directed mutagenesis, or deletions;
12/23/2004	US20040260058 Point mutations, deletions; quantitative/qualitative analysis; immunoassay; blot analysis; drug screening
12/23/2004	US20040259848 Applying fungicide to plants, crops
12/23/2004	US20040259831 Methods and compositions for the introduction of molecules into cells
12/23/2004	US20040259830 converting a peptide solution to aerosol droplets which are produced by a microflow nebulizer at a flow rate of 1-100 mu l/minute and impacting a bacterial cell with accelerated aerosol droplets; preferably placing the cell on a target surface with separately controlled linear and rotational movement
12/23/2004	US20040259829 Carboxylesterase; antitumor agents; drug screening; bioassay
12/23/2004	US20040259828 Intravascular delivery of non-viral nucleic acid
12/23/2004	US20040259825 Gene expression vectors; intensifier dor sequence determiantion; induce immunology response; viricides
12/23/2004	US20040259824 Antisense modulation of cd40 ligand expression
12/23/2004	US20040259822 Antibody which recognizes epitope containing nucleic acid coupled to active protein; hybridomas
12/23/2004	US20040259798 Drugs; integrin antagonist; antiinflammatory agents; leukemia therapy
12/23/2004	US20040259795 Reducing sepsis; binding polypeptide to monoclonal antibody ; intensify gene expression; wound healing agents
12/23/2004	US20040259785 CC chemokine receptor 5 DNA, new animal models and therapeutic agents for HIV infection
12/23/2004	US20040259783 Pharmaceutical compositions of marine sponge microciona prolifera
12/23/2004	US20040259781 Drug screening ; polypeptide interfers with binding of fibronectin to; anticancer agents; antihistamines, antiarthritic agents, autoimmune disease, wound healing agents
12/23/2004	US20040259780 Method for treating diabetes and obesity
12/23/2004	US20040259778 Utilization of histamine receptor h3 gene participating in body weight or food intake control
12/23/2004	US20040259776 Screening for apoptosis
12/23/2004	US20040259767 Antiproliferative agents; therapy for human progessive leukoencephalophy ; suppression of dna viruses; anticancer agents
12/23/2004	US20040259733 transforming a cell with a nucleotide sequence by using a microflow nebulizer to form aerosol droplets of a nucleic acid solution, and accelerating the droplets toward the cell; genetic engineering
12/23/2004	US20040259261 quality assurance; identifying reagents on the test array, then verifying whether reagents on said test array match those reagents loaded into the microdispenser; recording the image of an entire surface of said microarray by an image-recording device to inspect the droplets
12/23/2004	US20040259258 Regulation of prokaryotic gene expression with zinc finger proteins
12/23/2004	US20040259257 Nucleic acid having promoter activity and transformed plant containing the same
12/23/2004	US20040259256 Methods of unnatural amino acid incorporation in mammalian cells
12/23/2004	US20040259255 Helper virus-free AAV production
12/23/2004	US20040259253 making a transgenic mouse using a novel 3' gene trap cassette that does not encode a marker conferring antibiotic resistance and which can be used to efficiently trap, mutagenize, and identify previously unknown cellular genes
12/23/2004	US20040259252 Vector containing an enhanced p15a origin of replication
12/23/2004	US20040259250 Methods and compositions for modifying a receptor tyrosine kinase protein tyrosine kinase signal to an apoptotic signal in a cell
12/23/2004	US20040259248 RNA interference mediating small RNA molecules
12/23/2004	US20040259247 short interfering RNAs for use treating diseases, in protein separation or purification, in drug screening; cell with target gene-specific knockout phenotype; double stranded RNA; RNA fragments are the sequence-specific mediators of RNAi (RNA interference)
12/23/2004	US20040259243 using a cell line with increased sensitivity for infection for the rapid detection of enterovirus by innoculating the cells with the sample and observing; poliovirus, Coxsackie A virus, Coxsackie B virus, or echovirus; using transgenic buffalo green monkey kidney cell lines; producing enteroviruses
12/23/2004	US20040259229 Novel technology for genetic mapping
12/23/2004	US20040259222 Novel group of $g(a)-amylases and a method for identification and production of novel $g(a)-amylases
12/23/2004	US20040259215 Genes coding for dna replication and for proteins related to pathogenesis
12/23/2004	US20040259214 Preparation of animal feed containing bacterioferrins and vitamin b5; fermenting at least one microorganism of the Enterobacteriaceae family under conditions suitable for the formation of the cysK gene product cysteine synthase A
12/23/2004	US20040259210 Which encode bacteriophage signal peptides; for secretion of antibodies and/or fragment antigen binding fragments; cassettes; host cells
12/23/2004	US20040259208 Such as mounse transthyretin (mTTR) promoter (antibody); recombinant lentiviruses and transfer vectors for transgene delivery and gene therapy; blood coagulation factor IX; antihemopohilic factor
12/23/2004	US20040259207 Polynucleotide and polypeptide sequences of canine cathepsin S
12/23/2004	US20040259206 Polynucleotide and polypeptide sequences of monkey cathepsin S
12/23/2004	US20040259203 Prokaryotic glycosyltransferases, sialyltransferases, galactosyltransferases, and other enzymes involved with production of lipooligosaccharides; expression cassettes; host cells
12/23/2004	US20040259202 Novel angiogenesis inhibitor
12/23/2004	US20040259201 Recombinant surfactant protein D compositions and methods of use thereof
12/23/2004	US20040259199 32544, Novel human phospholipase C and uses thereof
12/23/2004	US20040259196 T cell receptor variants expressed in mesenchymal cells and uses thereof
12/23/2004	US20040259192 into two fragments, using the human matrix metalloproteinase MMP-3; administering 3-(3-mercaptopropyl)-1-methyl-(1H,3H)quinazoline-2,4-dione and/or 3-(2'-mercaptoethylamino)-2H-1,2,4-benzothiadiazine-1,1-dioxide to treat tumors or diabetic retinopathy; also wound healing, cardiac infarction treatment
12/23/2004	US20040259175 Human prostate cancer candidate protein 1
12/23/2004	US20040259171 P2Y4 antibody and methods of use
12/23/2004	US20040259166 Methods for designing inhibitors of serine/threonine kinases and tyrosine kinases
12/23/2004	US20040259165 Non-oligomerizing tandem fluorescent proteins
12/23/2004	US20040259162 container or multiwell plate for isolation of cellular components, such as polypeptides and nucleic acids, from host cells; interior surface comprising a sidewall formation and a bottom; a volume; a lytic reagent; and optionally a supported capture ligand
12/23/2004	US20040259156 Bispecific immunoglobulin-like antigen binding proteins and method of production
12/23/2004	US20040259155 e.g., a catalytic motif such as a serine protease triad or a binding motif such as a metal binding motif, into a polypeptide such as a polypeptide that binds to a ligand or substrate, e.g., an antibody or cytokine receptor; causing proteolysis of the target; biodrugs
12/23/2004	US20040259151 containing a prosthetic group and/or subunits on the surface of a host cell using the transporter domain of an autotransporter; use of host cell for toxicity monitoring, drug screening or synthesis of organic substances such as enzyme substrates, drugs, hormones, intermediates thereto
12/23/2004	US20040259145 Compositions and methods for the modification of gene expression
12/23/2004	US20040259140 Beta 1,3-galactosyltransferases from C. jejuni
12/23/2004	US20040259139 Novel proteins in enteroaggregative escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections
12/23/2004	US20040259137 Alpha 1-6 fucosyltransferase
12/23/2004	US20040259136 diagnosis of arthritis based on elevated test amount of a zeta PKC gene product; drug screening, antisense agents and short interfering RNA (siRNA)
12/23/2004	US20040259133 precipitation ribonucleic acids by incubating with preservative in an aqueous solutions, then staining and analyzing the cells for messenger ribonucleic acid expression patterns by fluorescence in-situ hybridization
12/23/2004	US20040259131 based on interactions between proximally-bound nucleic acid tags; interaction generating at least one tag having novel sequence; reagent kit containing Mosaic Ends recognition sequences, nucleic acid tags comprise LoxP sites, Cre recombinase and Tn5 transposase
12/23/2004	US20040259130 introducing a nucleic acid comprising a non-lethal marker gene into an avian cell by electroporating and allowing the cell to undergo a cellular division; injecting said cell into an avian embryo to produce a transgenic chick; use to make exogenous proteins such as human antibodies
12/23/2004	US20040259129 Compositions and methods for identifying genes whose products modulate biological processes
12/23/2004	US20040259123 isolated from Aeropyrum pernix, can stand heat treatment at 100 degrees C. and not lose its activity; host cells, nucleotide sequences, and vectors
12/23/2004	US20040259122 Autocatalysis/yeast two-hybrid assay
12/23/2004	US20040259119 apparatus; sequences are labelled and applied to an array of oligonucletides on at least two defined cells under hybridizing conditions; analysis of known point mutations, DNA fingerprinting, characterization of mRNAs, sequence determination; amplification not needed
12/23/2004	US20040259110 Gene PRV-1 and its use
12/23/2004	US20040259109 Method of analyzing prokaryotic gene expression
12/23/2004	US20040259103 NKR (Natural Killer Receptor); rapidly analyze physiological and pathological situations linked to these repertoires; use in diagnosise/prognosis of patients for transplant acceptance, resistance to infections and disease, and in drug screening for autoimmune diseases, antitumor agents, and antibiotics
12/23/2004	US20040259097 Method for the in vitro synthesis of short double stranded rnas
12/23/2004	US20040259096 Receptor capture assay
12/23/2004	US20040259093 aspirating a solution containing nucleic acids into a nucleic acid-capturing tip having a solid phase capable of capturing nucleic acids and discharging the aspirated solution; yield is improved by controlling the flow rate at which the sample solution is aspirated and discharged
12/23/2004	US20040259092 Nogo receptor homologues and their use
12/23/2004	US20040259090 Use of a biochip for the diagnosis of sepsis or sepsis related syndrome
12/23/2004	US20040259089 Mutant rna polymerases
12/23/2004	US20040259087 Diagnosing atherosclerosis by determining presence or absence of single nucleotide polymorphism (SNP) in codon of lipoprotein-associated phospholipase A2 (Lp-PLA2); point mutations; kits
12/23/2004	US20040259084 Diagnostic and therapeutic methods based on the l1 adhesion molecule for ovarian and endometrial tumors

1 ... 2111 2112 2113 2114 2115 2116 2117 2118 2119 2120 2121 2122 2123 2124 2125 2126 2127 2128 2129 2130 2131 ... 4023